2021
DOI: 10.1016/j.euroneuro.2020.11.019
|View full text |Cite
|
Sign up to set email alerts
|

Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

3
18
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(21 citation statements)
references
References 74 publications
3
18
0
Order By: Relevance
“…This suggestion was substantiated by the experiments with CB1R knockout mice (Figures 2, 4) showing no CP 55,940-induced CPA. Therefore, our results are consistent with the previous findings that support a role CB1R (Scherma et al, 2008;Soria-Gomez et al, 2015;Han et al, 2017;Navabpour et al, 2021), but contradictory to other findings that support a role CB2R (Aracil-Fernandez et al, 2012;Ortega-Alvaro et al, 2015;Spiller et al, 2019;Li et al, 2021), in CB-associated modulation of aversive effects. Although CP 55,940 is an analog of 9 -THC, it differs from 9 -THC not only in the efficacy of activating CB receptors (McGregor et al, 1996;Singh et al, 2011), but also possibly in the receptor mechanisms of regulating brain functions which include temperature (Grim et al, 2016) as well as rewarding and aversion responses (Singh et al, 2011).…”
Section: Discussionsupporting
confidence: 84%
See 3 more Smart Citations
“…This suggestion was substantiated by the experiments with CB1R knockout mice (Figures 2, 4) showing no CP 55,940-induced CPA. Therefore, our results are consistent with the previous findings that support a role CB1R (Scherma et al, 2008;Soria-Gomez et al, 2015;Han et al, 2017;Navabpour et al, 2021), but contradictory to other findings that support a role CB2R (Aracil-Fernandez et al, 2012;Ortega-Alvaro et al, 2015;Spiller et al, 2019;Li et al, 2021), in CB-associated modulation of aversive effects. Although CP 55,940 is an analog of 9 -THC, it differs from 9 -THC not only in the efficacy of activating CB receptors (McGregor et al, 1996;Singh et al, 2011), but also possibly in the receptor mechanisms of regulating brain functions which include temperature (Grim et al, 2016) as well as rewarding and aversion responses (Singh et al, 2011).…”
Section: Discussionsupporting
confidence: 84%
“…Although CP 55,940 is an analog of 9 -THC, it differs from 9 -THC not only in the efficacy of activating CB receptors (McGregor et al, 1996;Singh et al, 2011), but also possibly in the receptor mechanisms of regulating brain functions which include temperature (Grim et al, 2016) as well as rewarding and aversion responses (Singh et al, 2011). In our hands, 1 mg/kg CP 55,940 produces CPA, while Li et al (2021) reported the CPP of 1 mg/kg 9 -THC in mice. With regard to the direct effect of CBs on mice aversive behavior, our data convincingly reveal a role CB1R in mediating the CPA effect of CP 55,940 at a concentration of 1 mg/kg.…”
Section: Discussionmentioning
confidence: 50%
See 2 more Smart Citations
“…Acute CB2R activation has been shown to inhibit VTA DAergic neuronal firing and cocaine selfadministration (Zhang et al, 2014), possibly through decreased DA released into the NAc (Zhang et al, 2014;Chase et al, 2015;Galaj and Xi, 2019). Similarly, it has recently been shown that CB2R-null mice also show elevated DA levels in the NAc in response to THC, further implicated CB2R as important mediators of mesolimbic DA signaling (Li et al, 2021). The decreased sign-tracking behavior seen following CB2R antagonism/inverse agonism in our study may, therefore, be due to a compensatory increase in NAc-VTA receptor sensitivity and/or expression following prolonged inhibition during adolescence (Zhang et al, 2014).…”
Section: Discussionmentioning
confidence: 97%